Cart summary

You have no items in your shopping cart.

AMI-1

SKU: orb1225739

Description

A specific inhibitor of PRMTs (protein arginine methyltransferases), but not lysine methyltransferases; inhibits PRMT1 and Hmt1p with IC50s of 8.81 uM and 3.03 uM respectively; increases the ratio of Bax/Bcl-2, and leads to apoptosis and loss of migratory activity in several HCC cells,decreases the expression levels of H4R3me2s; strongly inhibits HCC growth in vivo.

Images & Validation

Key Properties

CAS Number20324-87-2
MW548.4534
Purity>98% (HPLC)
FormulaC21H14N2Na2O9S2
SMILESO=C(NC1=CC2=CC(S(=O)([O-])=O)=CC(O)=C2C=C1)NC3=CC4=CC(S(=O)([O-])=O)=CC(O)=C4C=C3.[Na+].[Na+]
TargetHMTase
SolubilityDMSO: ≥ 46 mg/mL

Bioactivity

In Vivo
AMI-1 (0.5 mg; intratumorally; daily; for 7 days) inhibits S180 viability In vivo. AMI-1 (0.5 mg; intratumorally; daily; for 7 days) downregulates PRMT5 but does not regulate the expression of PRMT7 in a tumor xenograft model. AMI-1 (0.5 mg; intratumorally; daily; for 7 days) decreases the levels of H4R3me2s and H3R8me2s in a tumor xenograft model. Animal model: 6-7 weeks old male Kunming mice (18-22 g), with S180 cells xenograft. Dosage: 0.5 mg. Administration: Intratumorally, daily, for 7 days. Result: Decreased tumor weight.
In Vitro
AMI-1 can inhibit the in vitro methylation reactions performed by all five recombinantly active PRMTs (PRMT1, -3, -4, and -6 and Hmt1p). AMI-1 not only inhibits type I PRMTs (PRMT1, 3, 4 and 6) but also type II PRMT5. AMI-1 specifically inhibits arginine, but not lysine, methyltransferase activity in vitro and does not compete for the AdoMet binding site. AMI-1 inhibits methylation of GFP-Npl3 and cellular proteins. AMI-1 (0.6-2.4 mM; 48-96 hours) inhibits the cell viability of sarcoma in S180 and U2OS cells in a time-dependent and dose-dependent manner in vitro. AMI-1 (1.2-2.4 mM; 48-72 hours) reduces S180 cell viability through the induction of cell apoptosis. Cell Viability Assay Cell line: S180 cells, U2OS cells. Concentration: 0.6 mM, 1.2 mM, 2.4 mM Incubation time: 48 hours, 72 hours, 96 hours. Result: Inhibited the cell viability. Apoptosis Analysis Cell line: S180 cells. Concentration: 1.2 mM, 2.4 mM Incubation time: 48 hours, 72 hours. Result: Increased the percentages of cells undergoing apoptosis.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

AMI-1 | AMI 1 | AMI1 | AMI-1 disodium salt.

Similar Products

  • AMI-1 [orb1305612]

    99.98%

    20324-87-2

    548.45

    C21H14N2Na2O9S2

    25 mg, 50 mg, 500 mg, 1 ml x 10 mM (in DMSO), 100 mg
  • AMI-1 free acid [orb1905872]

    97.80% (May vary between batches)

    134-47-4

    504.49

    C21H16N2O9S2

    25 mg, 1 ml x 10 mM (in DMSO), 100 mg, 1 g, 500 mg, 50 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

AMI-1 (orb1225739)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

5 mg
$ 90.00
10 mg
$ 110.00
25 mg
$ 200.00
50 mg
$ 270.00
100 mg
$ 410.00
500 mg
$ 950.00